Incidental Insights
Charles HooperCharles Hooper's Substack
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 78 | Subscribers | Read | incidentalinsights.substack.com |
Curious about how many subscribers Incidental Insights has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Deregulation Can Make Medications Cheaper
A month ago the Wall Street Journal published a short article that Solomon S. Steiner and I wrote. (David R. Henderson helped behind the scenes.) Here’s the full article:
Thalidomide Babies!
Recently Solomon Steiner and I wrote an op/ed for the Wall Street Journal suggesting that the U.S. government swap the FDA’s rules back to what they were between 1938 and 1962, when new drugs were required to pass the FDA’s assessment of sa...
Pharmaceutical Derangement Syndrome
We are all familiar with Trump Derangement Syndrome (TDS), which causes otherwise rational people to overreact to Donald Trump. Those with TDS blame Trump for anything and everything. They give him no credit and put their efforts into looki...
My WSJ Article and the (Mostly) Disappointing Online Comments
I was gratified to learn that the Wall Street Journal published a short piece (“Deregulation Can Make Medications Cheaper”) that Solomon S. Steiner and I wrote. This article might be one of the most important things I’ve ever written. It is...
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
President of Objective Insights, a life sciences consulting firm. Previously worked at NASA/Ames Research Center. Coauthor of "Making Great Decisions in Business and Life" and author of "Should the FDA Reject Itself?"
Frequently Asked Questions
How can I access the email archive for Incidental Insights?
You can find recent issues that have been published by Incidental Insights on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Incidental Insights have?
To see how many people subscribe to Incidental Insights, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Incidental Insights?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Incidental Insights as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Incidental Insights?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Incidental Insights using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Incidental Insights?
Scroll up to where it says Similar Newsletters to see other publications like Incidental Insights. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Incidental Insights?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.